Stockreport

AdaptHealth Corp (AHCO) Q3 2024 Earnings Call Highlights: Navigating Growth and Challenges [Yahoo! Finance]

AdaptHealth Corp. - Class A  (AHCO) 
PDF Diabetes Revenue: $141.1 million, decreased 11.8% year-over-year. Respiratory Revenue: $164 million, increased 8.6% year-over-year. Adjusted EBITDA: $164.3 million, [Read more]